iHuman $IH

Consumer Discretionary

$1.15
+0.01 (+0.88%)
As of Oct 5, 2026, 5:11 PM EDT
Price history
Loading chart…

iHuman (IH) is trading up at $1.15 (+0.88%), as of the latest quote. It operates in the Consumer Discretionary sector.

IPO: October 9, 2020 · $12.00 offering · NYSE · View IPO details →

iHuman revenue & net income history (FY2018–FY2025)

RevenueNet income
CN¥1.02BCN¥371.3M−CN¥275.6MFY2018 revenue: CN¥131.9MFY2018 net income: −CN¥17.6M'18FY2019 revenue: CN¥218.7MFY2019 net income: −CN¥275.6M'19FY2020 revenue: CN¥531.9MFY2020 net income: −CN¥37.5M'20FY2021 revenue: CN¥944.7MFY2021 net income: −CN¥37.1M'21FY2022 revenue: CN¥985.5MFY2022 net income: CN¥109.8M'22FY2023 revenue: CN¥1.02BFY2023 net income: CN¥180.9M'23FY2024 revenue: CN¥922.2MFY2024 net income: CN¥98.6M'24FY2025 revenue: CN¥807.0MFY2025 net income: CN¥95.4M'25
iHuman annual financial statements
FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
RevenueCN¥131.9MCN¥218.7MCN¥531.9MCN¥944.7MCN¥985.5MCN¥1.02BCN¥922.2MCN¥807.0M
Growth (year over year)—+65.8%+143.3%+77.6%+4.3%+3.3%−9.4%−12.5%
Gross profitCN¥66.0MCN¥134.5MCN¥365.4MCN¥660.6MCN¥691.2MCN¥721.3MCN¥640.2MCN¥547.6M
Gross margin50.1%61.5%68.7%69.9%70.1%70.8%69.4%67.9%
Operating income−CN¥22.1M−CN¥278.8M−CN¥44.5M−CN¥54.2MCN¥111.6MCN¥159.9MCN¥71.9MCN¥66.8M
Operating margin−16.7%−127.5%−8.4%−5.7%11.3%15.7%7.8%8.3%
Net income−CN¥17.6M−CN¥275.6M−CN¥37.5M−CN¥37.1MCN¥109.8MCN¥180.9MCN¥98.6MCN¥95.4M
Net margin−13.3%−126.0%−7.0%−3.9%11.1%17.8%10.7%11.8%
EPS (diluted)−CN¥0.11−CN¥1.52−CN¥0.21−CN¥0.14CN¥0.41CN¥0.66CN¥0.36CN¥0.36
Balance sheet
Cash and equivalentsCN¥6.12MCN¥104.9MCN¥861.7MCN¥855.4MCN¥1.05BCN¥1.21BCN¥1.12BCN¥1.15B
Total assets—CN¥168.3MCN¥1.05BCN¥1.10BCN¥1.33BCN¥1.45BCN¥1.42BCN¥1.37B
Total liabilities—CN¥182.8MCN¥404.3MCN¥492.5MCN¥563.9MCN¥492.7MCN¥458.8MCN¥373.2M
Shareholders' equity−CN¥63.7M−CN¥135.3MCN¥642.7MCN¥608.4MCN¥769.5MCN¥957.8MCN¥960.8MCN¥995.2M
Cash flow
Operating cash flow−CN¥4.50MCN¥42.6MCN¥223.0MCN¥38.2MCN¥188.5MCN¥172.1MCN¥58.5MCN¥51.3M
Capital expenditureCN¥529.0KCN¥2.39MCN¥15.9MCN¥32.3MCN¥6.59MCN¥6.51MCN¥7.45MCN¥4.90M
Free cash flow−CN¥5.03MCN¥40.2MCN¥207.1MCN¥5.93MCN¥181.9MCN¥165.6MCN¥51.1MCN¥46.4M
Dividends paid——————CN¥35.3MCN¥39.1M
Share buybacks———CN¥164.0KCN¥6.96MCN¥9.54MCN¥9.63MCN¥17.2M

From iHuman's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Amounts are in Chinese Yuan (CNY), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →

About iHuman

Headquarters
Beijing, China From SEC filings, Oct 2026

Recent News

No recent news mentioning iHuman in our feed yet.

More Consumer Discretionary stocks

Browse all companies →